随访梗死体积对血管内治疗与功能结局关系的中介作用
该研究汇总7项随机多中心试验共1665例急性缺血性卒中患者,分析随访梗死体积(FIV)是否中介血管内治疗(EVT)与90天功能结局的关系。结果显示EVT组FIV更小、mRS更低,FIV部分中介治疗与结局关系,但仅解释12%的治疗获益。
要点
- 随访梗死体积仅解释EVT与功能结局关系的12%(95%CI 1-19)。
- 随访梗死体积不能作为II/III期试验中估计治疗效应的有效替代指标。
核心结论
- 随访梗死体积可预测功能结局,但仅解释EVT治疗获益的12%。
- 随访梗死体积不是估计急性缺血性卒中试验治疗效应的有效替代指标。
研究设计与样本
- 汇总7项随机多中心试验,纳入1665例急性缺血性卒中患者,EVT组821例(49.3%),对照组844例(50.7%)。
- 随访梗死体积通过CT或MRI评估,采用中介分析检验EVT与90天mRS关系是否由FIV中介。
主要发现
- EVT组90天mRS中位数3(IQR 1-4),低于对照组4(IQR 2-5)。
关键数值与推荐
- 治疗减少的随访梗死体积解释EVT与功能结局关系的12%(95%CI 1-19)。
临床怎么用
- 临床解读EVT获益时不应仅以随访梗死体积缩小作为疗效替代指标。
- II/III期急性缺血性卒中试验不宜用随访梗死体积估计治疗效应。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The positive treatment effect of endovascular therapy (EVT) is assumed to be caused by the preservation of brain tissue. It remains unclear to what extent the treatment-related reduction in follow-up infarct volume (FIV) explains the improved functional outcome after EVT in patients with acute ischemic stroke. OBJECTIVE: To study whether FIV mediates the relationship between EVT and functional outcome in patients with acute ischemic stroke. DESIGN, SETTING, AND PARTICIPANTS: Patient data from 7 randomized multicenter trials were pooled. These trials were conducted between December 2010 and April 2015 and included 1764 patients randomly assigned to receive either EVT or standard care (control). Follow-up infarct volume was assessed on computed tomography or magnetic resonance imaging after stroke onset. Mediation analysis was performed to examine the potential causal chain in which FIV may mediate the relationship between EVT and functional outcome. A total of 1690 patients met the inclusion criteria. Twenty-five additional patients were excluded, resulting in a total of 1665 patients, including 821 (49.3%) in the EVT group and 844 (50.7%) in the control group. Data were analyzed from January to June 2017. MAIN OUTCOME AND MEASURE: The 90-day functional outcome via the modified Rankin Scale (mRS). RESULTS: Among 1665 patients, the median (interquartile range [IQR]) age was 68 (57-76) years, and 781 (46.9%) were female. The median (IQR) time to FIV measurement was 30 (24-237) hours. The median (IQR) FIV was 41 (14-120) mL. Patients in the EVT group had significantly smaller FIVs compared with patients in the control group (median [IQR] FIV, 33 [11-99] vs 51 [18-134] mL; P = .007) and lower mRS scores at 90 days (median [IQR] score, 3 [1-4] vs 4 [2-5]). Follow-up infarct volume was a predictor of functional outcome (adjusted common odds ratio, 0.46; 95% CI, 0.39-0.54; P < .001). Follow-up infarct volume partially mediated the relationship between treatment type with mRS score, as EVT was still significantly associated with functional outcome after adjustment for FIV (adjusted common odds ratio, 2.22; 95% CI, 1.52-3.21; P < .001). Treatment-reduced FIV explained 12% (95% CI, 1-19) of the relationship between EVT and functional outcome. CONCLUSIONS AND RELEVANCE: In this analysis, follow-up infarct volume predicted functional outcome; however, a reduced infarct volume after treatment with EVT only explained 12% of the treatment benefit. Follow-up infarct volume as measured on computed tomography and magnetic resonance imaging is not a valid proxy for estimating treatment effect in phase II and III trials of acute ischemic stroke.
引用
- Boers AMM, Jansen IGH, Brown S, et al. Mediation of the Relationship Between Endovascular Therapy and Functional Outcome by Follow-up Infarct Volume in Patients With Acute Ischemic Stroke. JAMA Neurol. 2019. PMID: 30615038. doi:10.1001/jamaneurol.2018.3661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。